Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	22.57B -6.2%
Revenue (ttm)	4.66B -18.7%
Net Income	64.62M -85.3%
EPS	0.13 -85.4%
Shares Out	478.36M
PE Ratio	349.24
Forward PE	41.94
Dividend	0.11 (0.25%)
Ex-Dividend Date	Jul 14, 2025

Volume	11,815,260
Average Volume	5,385,508
Open	45.83
Previous Close	44.83
Day's Range	45.67 - 48.92
52-Week Range	42.51 - 61.85
Beta	0.75
RSI	56.25
Earnings Date	Apr 23, 2026

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 3,860
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.